Ryan West, DO
Pain Medicine · Las Vegas, NVNPI 1467892919
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,689 of the $6,126 with a category attached, or 76.5%. Abbott accounts for 73.3% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $1,434 and has fallen 54.3% since, to $655 in 2025.
Across 175 payments — averaging $35.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Boston Scientific$600
- Medtronic$457
- Nevro Corp.$200
- Relievant Medsystems, Inc.$113
- Vertos Medical, Inc.$51
- plus $216 from 9 others
What the payments were for
- Travel & lodging$1,43823%
- Food & beverage$4,68977%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 138 | $4,490 |
| Boston Scientific | 12 | $600 |
| Medtronic(2 entities) | 7 | $457 |
| Nevro Corp. | 3 | $200 |
| Relievant Medsystems, Inc. | 1 | $113 |
| Vertos Medical, Inc. | 2 | $51 |
| Forte Bio-pharma LLC | 2 | $44 |
| Curonix LLC | 2 | $34 |
| SPR Therapeutics, Inc | 2 | $34 |
| Vertex | 1 | $21 |
| Protega Pharmaceutials Inc | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Saluda Medical Americas, Inc. | 1 | $18 |
| Nalu Medical, Inc. | 1 | $15 |
| Biotronik NRO, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Proclaim Family of SCS IPGs$1,069
- OCTRODE$456
- PENTA$431
- GENERAL PAIN MANAGEMENT$285
- PROCLAIM$276
- KYPHON Balloon Kyphoplasty$239
- ETERNA$226
- Intracept$226
- Senza$174
How this compares
$6,126 in reported general payments places this provider in the 70th percentile of 101 pain medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 74 | $2,612 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 137 | $2,507 |
| Gabapentin | 136 | $995 |
| Pregabalin | 32 | $518 |
| Methocarbamol | 42 | $271 |
| Tramadol Hcl | 57 | $242 |
| Celecoxib | 11 | $186 |
| Tizanidine Hcl | 34 | $173 |
| Meloxicam | 36 | $141 |
| Cyclobenzaprine Hcl | 16 | $80 |
| Cephalexin | 16 | $57 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Las Vegas
- Kunal ParikhLas Vegas$26K
- Nader HelmiLas Vegas$25K
- Sungkook ParkLas Vegas$20K
- Pouya MohajerLas Vegas$17K
- David AlvaradoLas Vegas$15K
- Okwuchukwu ObiLas Vegas$15K
- Christopher FisherLas Vegas$13K
- Andrew KimLas Vegas$11K
- Neville CampbellLas Vegas$11K
- Heerak KangLas Vegas$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.